1.
Siegel RL, Miller KD, Jemal A: Cancer statistics, 2016. CA: a cancer journal for clinicians 2016, 66(1):7-30.
2.
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J: Cancer statistics in China, 2015. CA: a cancer journal for clinicians 2016, 66(2):115-132.
3.
Marventano S, Forjaz M, Grosso G, Mistretta A, Giorgianni G, Platania A, Gangi S,
Basile F, Biondi A: Health related quality of life in colorectal cancer patients: state of the art. BMC surgery 2013, 13 Suppl 2:S15.
4.
Vacante M, Borzi AM, Basile F, Biondi A: Biomarkers in colorectal cancer: Current clinical utility and future perspectives. World journal of clinical cases 2018, 6(15):869-881.
5.
Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak
SD, Gregersen LH, Munschauer M et al: Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013, 495(7441):333-338.
6.
Ebbesen KK, Kjems J, Hansen TB: Circular RNAs: Identification, biogenesis and function. Biochimica et biophysica acta 2016, 1859(1):163-168.
7.
Suzuki H, Tsukahara T: A view of pre-mRNA splicing from RNase R resistant RNAs. International journal of molecular sciences 2014, 15(6):9331-9342.
8.
Chen S, Li T, Zhao Q, Xiao B, Guo J: Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric
cancer. Clinica chimica acta; international journal of clinical chemistry 2017, 466:167-171.
9.
Wang J, Li X, Lu L, He L, Hu H, Xu Z: Circular RNA hsa_circ_0000567 can be used as a promising diagnostic biomarker for
human colorectal cancer. Journal of Clinical Laboratory Analysis 2018, 32(5):e22379.
10.
Wang F, Wang J, Cao X, Xu L, Chen L: Hsa_circ_0014717 is downregulated in colorectal cancer and inhibits tumor growth by
promoting p16 expression. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018, 98:775-782.
11.
Wang X, Zhang Y, Huang L, Zhang J, Pan F, Li B, Yan Y, Jia B, Liu H, Li S et al: Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical significances. International journal of clinical and experimental pathology 2015, 8(12):16020-16025.
12.
Hsiao KY, Lin YC, Gupta SK, Chang N, Yen L, Sun HS, Tsai SJ: Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis. Cancer research 2017, 77(9):2339-2350.
13.
Zhang P, Zuo Z, Shang W, Wu A, Bi R, Wu J, Li S, Sun X, Jiang L: Identification of differentially expressed circular RNAs in human colorectal cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology
and Medicine 2017, 39(3):1010428317694546.
14.
Li J, Ni S, Zhou C, Ye M: The expression profile and clinical application potential of hsa_circ_0000711 in colorectal
cancer. Cancer management and research 2018, 10:2777-2784.
15.
Zeng K, Chen X, Xu M, Liu X, Hu X, Xu T, Sun H, Pan Y, He B, Wang S: CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell death & disease 2018, 9(4):417.
16.
Ji W, Qiu C, Wang M, Mao N, Wu S, Dai Y: Hsa_circ_0001649: A circular RNA and potential novel biomarker for colorectal cancer. Biochemical and biophysical research communications 2018, 497(1):122-126.
17.
Yuan Y, Liu W, Zhang Y, Zhang Y, Sun S: CircRNA circ_0026344 as a prognostic biomarker suppresses colorectal cancer progression
via microRNA-21 and microRNA-31. Biochemical and biophysical research communications 2018, 503(2):870-875.
18.
Fang G, Ye BL, Hu BR, Ruan XJ, Shi YX: CircRNA_100290 promotes colorectal cancer progression through miR-516b-induced downregulation
of FZD4 expression and Wnt/beta-catenin signaling. Biochemical and biophysical research communications 2018, 504(1):184-189.
19.
Li XN, Wang ZJ, Ye CX, Zhao BC, Huang XX, Yang L: Circular RNA circVAPA is up-regulated and exerts oncogenic properties by sponging
miR-101 in colorectal cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2019, 112:108611.
20.
Zhuo F, Lin H, Chen Z, Huang Z, Hu J: The expression profile and clinical significance of circRNA0003906 in colorectal cancer. OncoTargets and therapy 2017, 10:5187-5193.
21.
Weng W, Wei Q, Toden S, Yoshida K, Nagasaka T, Fujiwara T, Cai S, Qin H, Ma Y, Goel
A: Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target
in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer
Research 2017, 23(14):3918-3928.
22.
Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of clinical epidemiology 2009, 62(10):1006-1012.
23.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM,
Sterne JA, Bossuyt PM: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of internal medicine 2011, 155(8):529-536.
24.
Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality
of nonrandomized studies in meta-analyses. European journal of epidemiology 2010, 25(9):603-605.
25.
Wang Y, Jiang T, Jiang M, Gu S: Appraising growth differentiation factor 15 as a promising biomarker in digestive
system tumors: a meta-analysis. BMC cancer 2019, 19(1):177.
26.
Lei L, Wang J, Zhang L, Chen Y, Yuan P, Liu D: Meta-analysis of the clinical value of abnormally expressed long non-coding RNAs for
pancreatic cancer. Oncotarget 2017, 8(51):89149-89159.
27.
Li S, Ning Y: Estimation of covariate-specific time-dependent ROC curves in the presence of missing
biomarkers. Biometrics 2015, 71(3):666-676.
28.
Liu D, Zhou XH: Semiparametric estimation of the covariate-specific ROC curve in presence of ignorable
verification bias. Biometrics 2011, 67(3):906-916.
29.
Bohning D, Holling H, Patilea V: A limitation of the diagnostic-odds ratio in determining an optimal cut-off value
for a continuous diagnostic test. Statistical methods in medical research 2011, 20(5):541-550.
30.
Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM: The diagnostic odds ratio: a single indicator of test performance. Journal of clinical epidemiology 2003, 56(11):1129-1135.
31.
Huang X, Zhang W, Shao Z: Prognostic and diagnostic significance of circRNAs expression in hepatocellular carcinoma
patients: A meta‐analysis. Cancer Medicine 2019, 8(3):1148-1156.
32.
Huang X, Zhang W, Shao Z: Prognostic and diagnostic significance of circRNAs expression in lung cancer. Journal of Cellular Physiology 2019.